Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Aclaris Therapeutics (ACRS): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
14 analysts
Options Flow (P/C)
—
Avg Consensus PT
$9
+172.7%
Highest Price Target
$16
+365.1%
Lowest Price Target
$1
-70.9%
Short Interest
8.4%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Canaccord Genuity | Edward Nash— | +248.8% | $13 → $12 | Maintained | Buy |
| Nov 17, 2026 | Wedbush | Martin Fan — | -12.8% | $8 → $3 | Downgrade | Outperform→Neutral |